PubMed Health⌕ Search

Biomedical subjects

Chi-Ming Che

Publications and source records attributed to Chi-Ming Che.

At least 19 recordsLinked to original sources
PubMed2007

Platinum(II) complexes with pi-conjugated, naphthyl-substituted, cyclometalated ligands (RC N N): structures and photo- and electroluminescence.

The crystal structures and photophysical properties of mononuclear [(RC N N)PtX](ClO4)n ((RC N N)=3-(6'-(2''-naphthyl)-2'-pyridyl)isoquinolinyl and derivatives; X=Cl, n=0; X=PPh(3) or PCy(3), n=1), dinuclear [(RC N N)2Pt2(mu-dppm)](ClO4)2 (dppm=bis(diphenyphosphino)methyl) and trinuclear [(RC N N)3Pt3(mu-dpmp)](ClO4)3 (dpmp=bis(diphenylphosphinomethyl)phenylphosphine) complexes are presented. The crystal structures show extensive intra- and/or intermolecular pipi interactions; the two (RC N N) planes of [(RC N N)2Pt2(mu-dppm)](ClO4)2 (R=Ph, 3,5-tBu2Ph or 3,5-(CF3)2Ph) are in a nearly eclipsed configuration with torsion angles close to 0 degrees. [(RC N N)PtCl], [(RC N N)2Pt2(mu-dppm)](ClO4)2, and [(RC N N)3Pt3(mu-dpmp)](ClO4)3 are strongly emissive with quantum yields of up to 0.68 in CH2Cl2 or MeCN solution at room temperature. The [(RC N N)PtCl] complexes have a high thermal stability (T(d)=470-549 degrees C). High-performance light-emitting devices containing [(RC N N)PtCl] (R=H or 3,5-tBu2Ph) as a light-emitting material have been fabricated; they have a maximum luminance of 63,000 cd m(-2) and CIE 1931 coordinates at x=0.36, y=0.54.

Journal Article↗
PubMed2007

Topical delivery of silver nanoparticles promotes wound healing.

Wound healing is a complex process and has been the subject of intense research for a long time. The recent emergence of nanotechnology has provided a new therapeutic modality in silver nanoparticles for use in burn wounds. Nonetheless, the beneficial effects of silver nanoparticles on wound healing remain unknown. We investigated the wound-healing properties of silver nanoparticles in an animal model and found that rapid healing and improved cosmetic appearance occur in a dose-dependent manner. Furthermore, through quantitative PCR, immunohistochemistry, and proteomic studies, we showed that silver nanoparticles exert positive effects through their antimicrobial properties, reduction in wound inflammation, and modulation of fibrogenic cytokines. These results have given insight into the actions of silver and have provided a novel therapeutic direction for wound treatment in clinical practice.

Administration, Topical↗
PubMed2006

Quantitative structure-activity (affinity) relationship (QSAR) study on protonation and cationization of alpha-amino acids.

A quantitative structure-activity (affinity) relationship (QSAR) study is carried out to model the proton, sodium, copper, and silver cation affinities of alpha-amino acids (AA). Stepping multiple linear regression (MLR), partial least squares (PLS), and artificial neural network (ANN) approaches are applied to elucidate the multiple factors affecting these affinities. The MLR and PLS models reveal that the variation in proton affinity is attributed to the highest electrophilic superdelocalizability of nitrogen (major) and the number of rotatable bonds (minor) in AA. The noncovalent interactions, especially ion-dipole interactions, are responsible for the changes in Na+ affinity. The ionization potential, dipole moment of the side chain, and degree of linearity are the properties of AA that give the best correlation with the Cu+ and Ag+ affinities. The ANN models are developed to study the relationships (linear or nonlinear) between the molecular descriptors and binding affinities. The ANN models show higher predictive power. The QSAR models are used to study the binding forms of AA (neutral vs zwitterionic) upon protonation/cationization. To our knowledge, this is the first attempt to carry out a QSAR study on protonated/cationized AlphaAlpha to elucidate their binding properties. In virtue of the Na+ affinity ANN model, the Na+ affinities of dihydroxyphenylalanine (DOPA) were predicted. This work may pave the way for the success of applying similar approaches to peptides or proteins (with AA as the building blocks) in the future.

Amino Acids↗
PubMed2006

Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.

The development of gold(III) complexes as potential anticancer drugs with higher cytotoxicity and fewer side effects than existing metal anticancer drugs has been actively pursued in recent years. In this study, we explored the cellular pharmacological properties of gold(III) porphyrin 1a, an anticancer drug lead we previously described. The cytotoxicity study of gold(III) porphyrin 1a by naphthol blue black (NBB) staining assay demonstrated that the higher cytotoxicity of gold(III) porphyrin 1a was not related to its photosensitizing activity. Serum dependent test revealed that serum proteins exhibited lesser effects on the activity of gold(III) porphyrin 1a. In addition, in vivo and in vitro binding assays showed that gold(III) porphyrin 1a acted on DNA noncovalently, which was differently from cisplatin. Flow cytometric study indicated that gold(III) porphyrin 1a inhibited cell growth partly through abrogating cell cycle at G(0)-G(1), and induced apoptosis in SUNE1 cells. The enhanced expression of p53, a cell cycle-controlling and apoptosis-related protein, further demonstrated that the cell cycle arrest and apoptosis induced by gold porphyrin 1a were p53 dependent. Our results highlighted the potential of gold(III) porphyrin 1a as an anticancer drug.

Animals↗
PubMed2006

Alkene cyclopropanation catalyzed by Halterman iron porphyrin: participation of organic bases as axial ligands.

With the iron(III) complex of the Halterman iron porphyrin [P*Fe(Cl)] and ethyl diazoacetate (EDA) as catalyst and carbene source, respectively, styrene-type substrates were converted to cyclopropyl esters with high trans/cis ratio (not less than 12) and high enantioselectivity for the trans-isomers (74-86% ee). The isomeric distribution of the cyclopropyl esters so obtained is akin to that obtained from the previously reported Ru(II) counterpart [P*Ru(CO)]. A linear Hammett correlation log(k(X)/k(H)) = sigma(+)rho was observed with rho = -0.57 suggesting the involvement of an electrophilic cyclopropanating species derived from the iron(II) center as the reactive intermediate in the catalytic cycle. This is further supported by a dramatic decrease in the enantioselectivity and trans/cis ratio observed in an experiment of styrene cyclopropanation when the reaction mixture was deliberately exposed to air. Axial ligand effects on the selectivities was also investigated. Substantial improvement in trans/cis ratios could be achieved by addition of organic bases such as pyridine (py) and 1-methylimidazole (MeIm) to the catalytic reaction. The existence of axially ligated iron carbene moieties, [P*Fe(CHCO(2)Et)(py)] and [P*Fe(CHCO(2)Et)(MeIm)], was established by electrospray mass spectrometry. Study of secondary kinetic isotope effect indicated that a more product-like transition state was generated by addition of MeIm.

Alkenes↗
PubMed2006

One-pot synthesis of metal primary phosphine complexes from O=PCl2R or PCl2R. Isolation and characterization of primary alkylphosphine complexes of a metalloporphyrin.

Treatment of [Ru(II)(Por)(CO)] [Por = porphyrinato(2-)] and O=PCl(2)R [R = Ad (adamantyl), Bu(t), Bu(sec)] or PCl2Mes (Mes = mesityl) with LiAlH4 afforded primary alkyl- and arylphosphine complexes [Ru(II)(Por)(PH2R)2], which have been isolated in pure form and characterized by 1H NMR, 31P NMR, IR, and UV-vis spectroscopy and mass spectrometry. The structures of [Ru(II)(TTP)(PH2Ad)2] and [Ru(II)(F20-TPP)(PH2Mes)2] were determined by X-ray crystallography.

Chlorine↗
PubMed2006

Intermolecular amidation of unactivated sp2 and sp2 C-H bonds via palladium-catalyzed cascade C-H activation/nitrene insertion.

This communication describes the Pd(OAc)2-catalyzed intermolecular amidation reactions of unactivated sp2 and sp3 C-H bonds using primary amides and potassium persulfate. The substrates containing a pendent oxime or pyridine group were amidated with excellent chemo- and regioselectivities. It is noteworthy that reactive C-X bonds were well-tolerated and a variety of primary amides can be effective nucleophiles for the Pd-catalyzed C-H amidation reactions. For the reaction of unactivated sp3 C-H bonds, beta-amidation of 1 degrees sp3 C-H bonds versus 2 degrees C-H bonds is preferred. The catalytic reaction is initiated by chelation-assisted cyclopalladation involving C-H bond activation. Preliminary mechanistic study suggested that the persulfate oxidation of primary amides should generate reactive nitrene species, which then reacted with the cyclopalladated complex.

Journal Article↗
PubMed2006

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.

A series of cyclometalated gold(III) compounds [Au(m)(C(wedge)N(wedge)C)mL]n+ (m = 1-3; n = 0-3; HC(wedge)N(wedge)CH = 2,6-diphenylpyridine) was prepared by ligand substitution reaction of L with N-donor or phosphine ligands. The [Au(m)(C(wedge)N(wedge)C)mL]n+ compounds are stable in solution in the presence of glutathione. Crystal structures of the gold(III) compounds containing bridging bi- and tridentate phosphino ligands reveal the presence of weak intramolecular pi pi stacking between the [Au(C(wedge)N(wedge)C)]+ units. Results of MTT assays demonstrated that the [Au(m)(C(wedge)N(wedge)C)mL]n+ compounds containing nontoxic N-donor auxiliary ligands (2) exert anticancer potency comparable to that of cisplatin, with IC50 values ranging from 1.5 to 84 microM. The use of [Au(C(wedge)N(wedge)C)(1-methylimidazole)]+ (2 a) as a model compound revealed that the gold(III)-induced cytotoxicity occurs through an apoptotic cell-death pathway. The cell-free interaction of 2 a with double-stranded DNA was also examined. Absorption titration showed that 2 a binds to calf-thymus DNA (ctDNA) with a binding constant of 4.5 x 10(5) dm3 mol(-1) at 298 K. Evidence from gel-mobility-shift assays and viscosity measurements supports an intercalating binding mode for the 2 a-DNA interaction. Cell-cycle analysis revealed that 2 a causes S-phase cell arrest after incubation for 24 and 48 hours. The cytotoxicity of 3 b-g toward cancer cells (IC50 = 0.04-4.3 microM) correlates to that of the metal-free phosphine ligands (IC50 = 0.1-38.0 microM), with [Au2(C(wedge)N(wedge)C)2(mu-dppp)]2+ (3 d) and dppp (dppp = 1,2-bis(diphenylphosphino)propane) being the most cytotoxic gold(III) and metal-free compounds, respectively. Compound 3 d shows a cytotoxicity at least ten-fold higher than the other gold(III) analogues; in vitro cellular-uptake experiments reveal similar absorptions for all the gold(III) compounds into nasopharyngeal carcinoma cells (SUNE1) (1.18-3.81 ng/cell; c.f., 3 d = 2.04 ng/cell), suggesting the presence of non-gold-mediated cytotoxicity. Unlike 2 a, both gold(III) compounds [Au(C(wedge)N(wedge)C)(PPh3)]+ (3 a) (PPh3 = triphenylphosphine) and [Au2(C(wedge)N(wedge)C)2(mu-dppp)]2+ (3 d) interact only weakly with ctDNA and do not arrest the cell cycle.

Antineoplastic Agents↗
PubMed2006

Structures, photoluminescence, and reversible vapoluminescence properties of neutral platinum(II) complexes containing extended pi-conjugated cyclometalated ligands.

Reacting K2PtCl4 with the tridentate R-C(wedge)N(wedge)C-H2 ligands 2,6-di-(2'-naphthyl)-4-R-pyridine (R = H, 1a; Ph, 1b; 4-BrC6H4, 1c; 3,5-F2C6H3, 1d) in glacial acetic acid, followed by heating in dimethyl sulfoxide (DMSO), gave complexes [(R-C(wedge)N(wedge)C)Pt(DMSO)] (2a-d). In the crystal structures of 2a-c, the molecules are paired in a head-to-tail orientation with Pt...Pt separations >6.3 A, and there are extensive close C-H...pi (d = 2.656-2.891 A), pi...pi (d = 3.322-3.399 A), and C-H...O=S (d = 2.265-2.643 A) contacts. [(Ph-C(wedge)N(wedge)C)Pt(PPh3)] (3) was prepared by reacting 2b with PPh3. Reactions of 2a-d with bis(diphenylphosphino)methane (dppm) gave [(R-C(wedge)N(wedge)C)2Pt2(mu-dppm)] (4a-d). Both head-to-head (syn) and head-to-tail (anti) conformations were found for 4a.6CHCl3.C5H12, whereas only one conformation was observed for 4b.2CHCl3 (syn), 4c.3CH2Cl2 (syn), and 4d.2CHCl3 (anti). In the crystal structures of 4a-d, there are close intramolecular Pt...Pt contacts of 3.272-3.441 A in the syn conformers, and long intramolecular Pt...Pt separations of 5.681-5.714 A in the anti conformers. There are weak C-H...X (d = 2.497-3.134 A) and X...X (X = Cl or Br; d = 2.973-3.655 A) interactions between molecules 4a-d and occluded CHCl3/CH2Cl2 molecules, and their solvent channels are of varying diameters (approximately 9-28 A). Complexes 2a-d, 3, and 4a-d are photoluminescent in the solid state, with emission maxima at 602-643 nm. Upon exposure to volatile organic compounds, 4a shows a fast and reversible vapoluminescent response, which is most intense with volatile halogenated solvents (except CCl4). Powder X-ray diffraction analysis of desolvated 4a revealed a more condensed molecular packing of syn and anti complexes than crystal 4a.6CHCl3.C5H12.

Cyclization↗
PubMed2006

Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.

Bismuth subcarbonate ((BiO)2CO3) nanotubes with uniform diameters of about 3-5 nm were fabricated from bismuth citrate; these nanotubes exhibit antibacterial properties against Helicobacter pylori (50% inhibition at 10 microg mL(-1)), a bacterium causing peptic ulcers and gastritis.

Anti-Bacterial Agents↗
PubMed2006

Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction.

[reaction: see text] Propargylamines have been synthesized by a gold(III) salen complex-catalyzed three-component coupling reaction of aldehydes, amines, and alkynes in water in excellent yields at 40 degrees C. With chiral prolinol derivatives as the amine component, excellent diastereoselectivities (up to 99:1) have been attained. This coupling reaction has been applied to the synthesis of propargylamine-modified artemisinin derivatives with the delicate endoperoxide moieties remaining intact. Cytotoxicities with IC(50) values up to 1.1 microM against a human hepatocellular carcinoma cell line (HepG2) were exhibited by these artemisinin derivatives.

Artemisinins↗